Expert Pitch

Renewables take a blow from coronavirus, but recovery expected

Cornell University
31-Mar-2020 11:50 AM EDT, by Cornell University

Wind, solar and battery industries have suffered with the spread of the coronavirus and reports from industry leaders forecast cutbacks and erasing of growth.

John Tobin is professor of practice at the SC Johnson College of Business at Cornell University, an expert on environmental and energy economics and a faculty fellow at the Cornell Atkinson Center for Sustainability. He says that the pandemic, combined with falling oil prices, is detrimental to renewables in the short term, but that the sector will recover with the help of long-term growth in market demand.

Bio: https://dyson.cornell.edu/faculty-research/faculty/jt728/

Tobin says:

“In the short term, investments in alternative energy are likely to be strongly impacted by the COVID-19 pandemic and the ongoing oil price war between two of the biggest oil producers in the world. The impact of the pandemic on the real economy is going to be severe, at least in the short term, and will put a damper on capital expenditures throughout the economy, including on solar, wind, and battery power.

“Add to this the fact that the 2016 oil production agreement between Russia and Saudi Arabia seems to have fallen apart and the price of oil is now lower than it has been for nearly 20 years means that the price incentive to switch to alternative power is not quite there.

“However, the economy will recover and the price of oil will climb back up to more realistic levels—and the growth of alternative energy is part of a secular trend resulting from growing market demand, pressure from policymakers, and a recognition of the negative impacts of fossil fuels. The medium- and long-term outlook of the alternative energy sector does not look materially different at this point compared to before the COVID-19 pandemic.”

Please find other experts at Cornell available to discuss the coronavirus crisis from a science  and public health perspectivefor its impact on the economy and in the ways the pandemic is changing our daily lives.

- 30 -




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
2.82059